Aion Therapeutic Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Aion Therapeutic has a total shareholder equity of CA$1.0M and total debt of CA$1.9M, which brings its debt-to-equity ratio to 187.8%. Its total assets and total liabilities are CA$5.9M and CA$4.9M respectively.
Belangrijke informatie
187.8%
Verhouding schuld/eigen vermogen
CA$1.94m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CA$349.28k |
| Aandelen | CA$1.03m |
| Totaal verplichtingen | CA$4.85m |
| Totaal activa | CA$5.89m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: AION's short term assets (CA$884.6K) do not cover its short term liabilities (CA$4.9M).
Langlopende schulden: AION has no long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: AION's net debt to equity ratio (154%) is considered high.
Schuld verminderen: AION's debt to equity ratio has increased from 51.1% to 187.8% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if AION has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if AION has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.